Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sramek

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Schizophrenia Bulletin|January 1, 1996
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalT M Shiovitz, T L Welke, P D Tigel, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1991
Idioventricular rhythm: hypervagotonia associated with placeboN R Cutler, A H Heller, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1995
Evaluation of cycloserine in the treatment of Alzheimer's diseaseT D Fakouhi, S S Jhee, J J Sramek, et al.
Frontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.
CNS Neuroscience & Therapeutics|February 6, 2016
Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal SubjectsJohn J Sramek, Larry W Hardy, Peter Bieck, et al.
Journal of Clinical Psychopharmacology|December 1, 1996
Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging studyJ J Sramek, A Fresquet, G Marion-Landais, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adultsD E Salazar, E J Frackiewicz, R Dockens, et al.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Schizophrenia Bulletin|January 1, 1996
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalT M Shiovitz, T L Welke, P D Tigel, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1991
Idioventricular rhythm: hypervagotonia associated with placeboN R Cutler, A H Heller, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1995
Evaluation of cycloserine in the treatment of Alzheimer's diseaseT D Fakouhi, S S Jhee, J J Sramek, et al.
Frontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.
CNS Neuroscience & Therapeutics|February 6, 2016
Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal SubjectsJohn J Sramek, Larry W Hardy, Peter Bieck, et al.
Journal of Clinical Psychopharmacology|December 1, 1996
Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging studyJ J Sramek, A Fresquet, G Marion-Landais, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adultsD E Salazar, E J Frackiewicz, R Dockens, et al.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Pageof 13